Overview
- 7 inspections across 7 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2008-09-28.
At a glance
Inspections
7
Sites
7
Observations
0
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Novast Laboratories Ltd. | 28 Sep 2008 | On file | |
| Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API) | 19 Sep 2008 | On file | |
| Guilin Pharmaceutical Co., Ltd. | 12 Sep 2008 | On file | |
| Sanofi Winthrop Industrie | 13 Mar 2008 | On file | |
| Olon SpA | 22 Feb 2008 |
Sites inspected
Novast Laboratories Ltd.Nantong, China1 insp.
Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API)Xianju, China1 insp.
Guilin Pharmaceutical Co., Ltd.Guilin, China1 insp.
Sanofi Winthrop IndustrieAramon, France1 insp.
Olon SpAMulazzano, Italy1 insp.
Full investigator report
Get the verbatim findings behind Susan F Laska's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site